Changes in Liver and Splenic Stiffness after Direct-Acting Antiviral Therapy in Chronic Hepatitis C: A Single-Centre, Prospective, Observational Study

Figure 5

Changes in spleen stiffness measurements (SSM) in the high SSM group stratified by a liver stiffness measurement (LSM) value of 1.93 m/s in patients with chronic hepatitis C treated with direct acting antivirals. (a) LSM <1.93 m/s (n =34). (b) LSM ≥1.93 m/s (n =14). Bars indicate Bonferroni-corrected p-values <0.05. Abbreviations: LSM, liver stiffness measurement; SSM, spleen stiffness measurement; PRE, pre-treatment; EOT, end of treatment; SVR48, 48 weeks after EOT; SVR96, 96 weeks after EOT.

(a)

(b)